Samsung Biologics Launches 1.8 Billion Dollar Bid for Swiss Peptide Maker PolyPeptide
The largest M&A deal by a Korean biotech company positions Samsung to capitalize on the booming GLP-1 obesity drug market.
The largest M&A deal by a Korean biotech company positions Samsung to capitalize on the booming GLP-1 obesity drug market.
The latest FedViews report shows PCE inflation at 4.1 percent, with markets now pricing in interest rate increases for the second half of 2026.
Boston sweeps the Rays and matches the 1948 team with a run not seen since the Ted Williams era, vaulting into wild card contention.
Pharma giant acquires DMT-based treatment developer to challenge growing psychedelic therapy market for treatment-resistant depression.
Federal Reserve voting member Jeff Schmid says strong demand continues driving price increases, pushing back against optimism that rate cuts are imminent.
Boston rallies from three-run deficit in seventh inning behind Wilyer Abreu's two home runs to claim longest franchise winning streak since 1948.
AI agent startups attracted .8 billion in funding in July 2026 alone, with enterprise automation and developer tools leading the charge as investors bet on the future of autonomous work.
Existing home sales dropped 2.4% in June even as the median price reached a record 40,600, highlighting the affordability crisis squeezing American homebuyers.